 Alleles
"Alleles" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product.
| Descriptor ID |
D000483
|
| MeSH Number(s) |
G05.360.340.024.340.030
|
| Concept/Terms |
Alleles- Alleles
- Allele
- Allelomorphs
- Allelomorph
|
Below are MeSH descriptors whose meaning is more general than "Alleles".
Below are MeSH descriptors whose meaning is more specific than "Alleles".
This graph shows the total number of publications written about "Alleles" by people in this website by year, and whether "Alleles" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 5 | 6 | | 1997 | 0 | 4 | 4 | | 1998 | 0 | 7 | 7 | | 1999 | 3 | 9 | 12 | | 2000 | 2 | 7 | 9 | | 2001 | 1 | 15 | 16 | | 2002 | 0 | 12 | 12 | | 2003 | 3 | 11 | 14 | | 2004 | 0 | 20 | 20 | | 2005 | 1 | 16 | 17 | | 2006 | 4 | 17 | 21 | | 2007 | 2 | 25 | 27 | | 2008 | 6 | 20 | 26 | | 2009 | 3 | 27 | 30 | | 2010 | 5 | 22 | 27 | | 2011 | 3 | 26 | 29 | | 2012 | 2 | 22 | 24 | | 2013 | 1 | 31 | 32 | | 2014 | 5 | 26 | 31 | | 2015 | 5 | 32 | 37 | | 2016 | 1 | 30 | 31 | | 2017 | 9 | 34 | 43 | | 2018 | 7 | 26 | 33 | | 2019 | 3 | 32 | 35 | | 2020 | 2 | 19 | 21 | | 2021 | 4 | 27 | 31 | | 2022 | 1 | 13 | 14 | | 2023 | 0 | 10 | 10 | | 2024 | 6 | 14 | 20 | | 2025 | 3 | 15 | 18 | | 2026 | 0 | 5 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Alleles" by people in Profiles.
-
Pointer MD, Nash WJ, Gage MJG, Chapman T, Maklakov AA, Richardson DS. Sexual selection purges mutation load, but not overall genetic diversity, decreasing vulnerability to extinction. Proc Natl Acad Sci U S A. 2026 Sep 15; 123(37):e2608675123.
-
da Silva FV, Hoch VB, Auer ED, Dos Santos PI, Cline N, Oliveira LC, Hundt JE, Wittig M, Franke A, Norman PJ, Boldt ABW. Genetics of Celiac Disease in Southern Brazil: High-Resolution HLA Haplotypes and Non-HLA Polymorphisms. HLA. 2026 Sep; 108(3):e70972.
-
Sadeeq SA, Leaton LA, Kichula KM, Farias TDJ, Font-Porterias N, Pollock NR, Collora CE, Castelli EC, Gignoux CR, Norman PJ. PONG 2.0: allele imputation for the killer cell immunoglobulin-like receptors. Hum Mol Genet. 2026 Aug 10; 35(17).
-
Font-Porterias N, Nemat-Gorgani N, Kichula KM, Al-Hindi DR, Harrison GF, Tao S, Zhu F, Montero-Martin G, Fernández-Viña MA, Guethlein LA, Parham P, Oppenheimer SJ, Ioannidis AG, Moreno-Estrada A, Pomat W, Mentzer AJ, Henn BM, Norman PJ. Signatures of pathogen-driven selection and Austronesian gene flow of Papua New Guinea HLA alleles. Am J Hum Genet. 2026 Jun 04; 113(6):1175-1193.
-
Starosta RT, He M, Gracie S, Kierstein J, Thiel C, Himmelreich N, Liu Y, Zhang W, Edmondson AC, Meeks N, Larson A, Van Hove JLK, Kochhar A. L-fucose supplementation in a patient with global hypofucosylation and a mono-allelic variant in SLC35C1: Clinical improvement and assessment of biomarkers. Mol Genet Metab. 2026 Mar; 147(3):109727.
-
Doss RM, Wirth SA, Pitsch JW, Dias CM, Gropman AL, Breuss MW. Exon-skipping due to bi-allelic splice site mutations in the neurodevelopmental disease gene LNPK. HGG Adv. 2026 Jan 15; 7(1):100543.
-
Liao SY, Fingerlin TE, Jacobson S, Mroz MM, Rosenman KD, Rossman MD, Virji M, McCanlies EC, Schuler CR, Yucesoy B, Glessner J, Duke JL, Hakonarson H, Monos DS, Maier LA. Genome-wide association study and HLA genotyping for beryllium disease susceptibility in a European descent population. Gene. 2025 Nov 05; 971:149820.
-
Daines CL, Polineni D, Tullis E, Costa S, Linnemann RW, Mall MA, McKone EF, Quon BS, Ringshausen FC, Selvadurai H, Taylor-Cousar JL, Withers NJ, Sawicki GS, Lee T, Ahluwalia N, Morlando Geiger J, Jennings M, Tan YV, Waltz D, Ramsey B, Griese M. Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Adults and Adolescents with Cystic Fibrosis and at Least One F508del Allele: A Phase 3 Open-Label Extension Study. Am J Respir Crit Care Med. 2025 10; 211(10):1901-1914.
-
Wainwright C, McColley SA, McNally P, Powers M, Ratjen F, Rayment JH, Retsch-Bogart G, Roesch E, Ramsey B, McKone EF, Tullis E, Mall MA, Taylor-Cousar JL, Waltz D, Ahluwalia N, Chu C, Scirica CV, Davies JC. Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Children =6 Years with Cystic Fibrosis and at Least One F508del Allele: A 192-Week, Phase 3, Open-Label Extension Study. Am J Respir Crit Care Med. 2025 10; 211(10):1915-1925.
-
Mumme-Monheit A, Gustafson GE, Hopkins CA, Bailon-Zambrano R, Sucharov J, Lippincott MJ, Way GP, Colborn KL, Nichols JT. A quadratic paradigm describes the relationship between phenotype severity and variation. Nat Commun. 2025 Sep 01; 16(1):8154.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|